Tonix Pharmaceuticals
TNXP
$0.17
Share price
5.31%
Change (1 day)
-61.70%
Change (1 year)
Categories
Tonix Pharmaceuticals (TNXP) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $18.44 M
According to Tonix Pharmaceuticals's latest financial reports the company's total liabilities are $18.44 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Tonix Pharmaceuticals - Total liabilities on balance sheet (from 2008 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $18.5 M | -16.57% |
| 2021-12-31 | $22.18 M | 110.56% |
| 2020-12-31 | $10.53 M | 104.92% |
| 2019-12-31 | $5.14 M | 93.63% |
| 2018-12-31 | $2.65 M | 24.18% |
| 2017-12-31 | $2.13 M | -0.51% |
| 2016-12-31 | $2.14 M | -68.19% |
| 2015-12-31 | $6.75 M | 95.83% |
| 2014-12-31 | $3.45 M | 55.13% |
| 2013-12-31 | $2.22 M | 92.06% |
| 2012-12-31 | $1.15 M | -59.78% |
| 2011-12-31 | $2.87 M | 701.04% |
| 2010-12-31 | $0.35 M | 36281.78% |
| 2009-12-31 | $0 M | -67.07% |
| 2008-12-31 | $0 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Aerie Pharmaceuticals AERI | $0.53 B | 2,824.67% | 🇺🇸 USA |
 Eagle Pharmaceuticals
EGRX | $0.15 B | 728.13% | 🇺🇸 USA |